(Q40339973)

19 September 2017

Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors (English)

1 reference

19 September 2017

8

1 reference

19 September 2017

Dullaers M

1

1 reference

19 September 2017

Van Meirvenne S

2

1 reference

19 September 2017

Heirman C

3

1 reference

19 September 2017

Straetman L

4

1 reference

19 September 2017

Bonehill A

5

1 reference

19 September 2017

Aerts JL

6

1 reference

19 September 2017

Thielemans K

7

1 reference

19 September 2017

1 April 2006

1 reference

19 September 2017

1 reference

19 September 2017

13

1 reference

19 September 2017

7

1 reference

19 September 2017

630-640

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302697

19 September 2017

0 references

cites work

T cell defined tumor antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Immunobiology of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Generation of large numbers of dendritic cells in a closed system using Cell Factories.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Nonviral transfection of distinct types of human dendritic cells: high-efficiency gene transfer by electroporation into hematopoietic progenitor- but not monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Biased epitope selection by recombinant vaccinia-virus (rVV)-infected mature or immature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Immunization of Patients with Malignant Melanoma with Autologous CD34+ Cell-Derived Dendritic Cells Transduced Ex Vivo with a Recombinant Replication-Deficient Vaccinia Vector Encoding the Human Tyrosinase Gene: A Phase I Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Monoclonal Anti-MAGE-3 CTL Responses in Melanoma Patients Displaying Tumor Regression after Vaccination with a Recombinant Canarypox Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Lentiviral-mediated gene delivery in human monocyte-derived dendritic cells: optimized design and procedures for highly efficient transduction compatible with clinical constraints

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Viral vectors for dendritic cell-based immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Dendritic cells as therapeutic vaccines against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Dendritic cell vaccines for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Functional analysis of tumor-specific Th cell responses detected in melanoma patients after dendritic cell-based immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Intravenous injection of a lentiviral vector encoding NY-ESO-1 induces an effective CTL response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: implications for cancer immunotherapy protocols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Mini-review CD4 T cells are required for CD8 T cell memory generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Helper T cells, dendritic cells and CTL Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Plasmacytoid dendritic cells in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Lentiviral vector-mediated tyrosinase-related protein 2 gene transfer to dendritic cells for the therapy of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Helper role of NK cells during the induction of anticancer responses by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Natural-killer cells and dendritic cells: "l'union fait la force".

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

In vivo depletion of CD4+CD25+ regulatory T cells enhances the antigen-specific primary and memory CTL response elicited by mature mRNA-electroporated dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

Use of a lentiviral flap vector for induction of CTL immunity against melanoma. Perspectives for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

7 January 2021

Lentivirally transduced dendritic cells as a tool for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

7 January 2021

Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

7 January 2021

Development of a self-inactivating lentivirus vector.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

7 January 2021

Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

7 January 2021

Efficient genetic modification of murine dendritic cells by electroporation with mRNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

7 January 2021

HIV infection and pasteurisation of breast milk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

7 January 2021

A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

7 January 2021

Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302697

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302697

1 reference

Dimensions Publication ID

19 September 2017

0 references

1 reference